| Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1341-1352, 2015 | 1316 | 2015 |
| Prognostic significance of autoimmunity during treatment of melanoma with interferon H Gogas, J Ioannovich, U Dafni, C Stavropoulou-Giokas, K Frangia, ... New England Journal of Medicine 354 (7), 709-718, 2006 | 767 | 2006 |
| Adiponectin and breast cancer risk C Mantzoros, E Petridou, N Dessypris, C Chavelas, M Dalamaga, ... The Journal of Clinical Endocrinology & Metabolism 89 (3), 1102-1107, 2004 | 719 | 2004 |
| Adjuvant tamoxifen and exemestane in early breast cancer (TEAM): a randomised phase 3 trial CJH Van de Velde, D Rea, C Seynaeve, H Putter, A Hasenburg, ... The Lancet 377 (9762), 321-331, 2011 | 479 | 2011 |
| Association between age at diagnosis and disease-specific mortality among postmenopausal women with hormone receptor–positive breast cancer W van de Water, C Markopoulos, CJH van de Velde, C Seynaeve, ... Jama 307 (6), 590-597, 2012 | 260 | 2012 |
| Estrogen receptor and progesterone receptor as predictive biomarkers of response to endocrine therapy: a prospectively powered pathology study in the Tamoxifen and Exemestane … JMS Bartlett, CL Brookes, T Robson, CJH van de Velde, LJ Billingham, ... Journal of clinical oncology 29 (12), 1531-1538, 2011 | 239 | 2011 |
| Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer JC Gazet, HT Ford, JM Bland, RC Coombes, RC Dixon The Lancet 331 (8587), 679-681, 1988 | 187 | 1988 |
| Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel P Hadji, RE Coleman, C Wilson, TJ Powles, P Clézardin, M Aapro, ... Annals of Oncology 27 (3), 379-390, 2016 | 184 | 2016 |
| Leptin and insulin growth factor I in relation to breast cancer (Greece) E Petridou, Y Papadiamantis, C Markopoulos, E Spanos, N Dessypris, ... Cancer causes & control 11, 383-388, 2000 | 174 | 2000 |
| Impact of breast cancer surgery on the self-esteem and sexual life of female patients C Markopoulos, AK Tsaroucha, E Kouskos, D Mantas, Z Antonopoulou, ... Journal of International Medical Research 37 (1), 182-188, 2009 | 163 | 2009 |
| The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN … A Karakatsanis, PM Christiansen, L Fischer, C Hedin, L Pistioli, M Sund, ... Breast cancer research and treatment 157, 281-294, 2016 | 144 | 2016 |
| Mutational analysis of PI3K/AKT signaling pathway in tamoxifen exemestane adjuvant multinational pathology study VS Sabine, C Crozier, CL Brookes, C Drake, T Piper, CJH van de Velde, ... Journal of Clinical Oncology 32 (27), 2951-2958, 2014 | 143 | 2014 |
| Oestrogen receptor content of normal breast cells and breast carcinomas throughout the menstrual cycle C Markopoulos, UTA Berger, P Wilson, JC Gazet, RC Coombes Br Med J (Clin Res Ed) 296 (6633), 1349-1351, 1988 | 141 | 1988 |
| Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations GN Tsaousis, E Papadopoulou, A Apessos, K Agiannitopoulos, G Pepe, ... BMC cancer 19, 1-19, 2019 | 135 | 2019 |
| Heterogeneous HER2 Gene Amplification: Impact on Patient Outcome and a Clinically Relevant Definition AI Bartlett, J Starcyznski, T Robson, A MacLellan, FM Campbell, ... American journal of clinical pathology 136 (2), 266-274, 2011 | 122 | 2011 |
| Postoperative dose-dense sequential chemotherapy with epirubicin, followed by CMF with or without paclitaxel, in patients with high-risk operable breast cancer: a randomized … G Fountzilas, D Skarlos, U Dafni, H Gogas, E Briasoulis, D Pectasides, ... Annals of oncology 16 (11), 1762-1771, 2005 | 121 | 2005 |
| Bilateral breast cancer. J Gogas, C Markopoulos, P Skandalakis, H Gogas The American Surgeon 59 (11), 733-735, 1993 | 104 | 1993 |
| Expression of alpha-thymosins in human tissues in normal and abnormal growth. OE Tsitsiloni, J Stiakakis, A Koutselinis, J Gogas, C Markopoulos, ... Proceedings of the National Academy of Sciences 90 (20), 9504-9507, 1993 | 94 | 1993 |
| Management of anastrozole-induced bone loss in breast cancer patients with oral risedronate: results from the ARBI prospective clinical trial C Markopoulos, E Tzoracoleftherakis, A Polychronis, B Venizelos, U Dafni, ... Breast cancer research 12, 1-12, 2010 | 91 | 2010 |
| Specific adverse events predict survival benefit in patients treated with tamoxifen or aromatase inhibitors: an international tamoxifen exemestane adjuvant multinational trial … DBY Fontein, C Seynaeve, P Hadji, ETM Hille, W Van De Water, H Putter, ... Journal of Clinical Oncology 31 (18), 2257-2264, 2013 | 84 | 2013 |
